Skip to content

Construction of regional collaborative chronic disease prevention and control pathways and strategies from the perspective of hierarchical diagnosis and treatment

Construction of regional collaborative chronic disease prevention and control pathways and strategies from the perspective of hierarchical diagnosis and treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120575
Enrollment
Unknown
Registered
2026-03-17
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes comorbidity

Interventions

Observation group:None
Control group:None

Sponsors

Shanghai Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years old. 2. Meet the diagnostic criteria for type 2 diabetes according to the WHO (1999). 3. Have at least one comorbidity other than diabetes (such as hypertension, dyslipidemia, coronary heart disease, chronic kidney disease stages 1-3, etc.), referred to as "diabetes comorbidity". 4. Have established a health record and undergone routine management at a community health service center within the medical consortium for >=6 months. 5. Provide informed consent, voluntarily participate in this study, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes, gestational diabetes, or other special types of diabetes. 2. Concurrent severe cardiac, hepatic, or renal insufficiency (such as NYHA class III-IV heart failure, decompensated liver cirrhosis, eGFR < 30 ml/min/1.73m^2, or dialysis patients). 3. Concurrent malignancy (except for those with stable disease for more than 5 years), acute infection, severe mental or cognitive impairment, and inability to cooperate with researchers. 4. Life expectancy < 1 year. 5. Participation in other interventional clinical studies within the past 3 months. 6. Other situations deemed unsuitable for participation in this study by the researchers (such as long-term residence outside the local area, planned relocation, etc.).

Design outcomes

Primary

MeasureTime frame
Glycosylated hemoglobin, HbA1c;

Secondary

MeasureTime frame
Other metabolic indicators (fasting blood glucose, 2-hour postprandial blood glucose, lipid profile, blood pressure);Patient-reported outcomes(Chinese version of the Diabetes Self-Management Behavior Scale (SDSCA), European Quality of Life-5 Dimensions (EQ-5D-5L));Management process indicators (referral rate, referral compliance rate, protocol adherence rate, follow-up completion rate);

Countries

China

Contacts

Public ContactXu Zhongqing

Shanghai Tongren Hospital

zhongqing_xu@126.com+86 133 1173 1577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026